Case Report: Wound Care of a Diabetic Foot Ulcer
Download in electronic PDF format for $75
Abstract: Wound care is one of the main concerns of patients with diabetes. This case involves a 65-year-old woman with a wound (4 cm x 2 cm) on her right foot, underneath the big toe. The patient had not been successful in healing this wound using conventional preparations for a year. A decision was made to compound a wound-care gel formulation, and two preparations were compounded. One contained phenytoin 3% and misoprostol 0.0024% gel and was used for wound healing. The patient was instructed to cover the wound twice daily with about 0.2 mL of this preparation. The other preparation was nifedipine 10% in a Pluronic lecithin organogel 20%. The patient was instructed to apply 0.6 mL twice daily around the wound and callous surrounding the wound and up the foot to increase circulation to the wound area. Saline rinses, which the patient had already been using, were continued as before (with application of the nifedipine gel afterward, followed by application of the phenytoin/misoprostol formulation). The wound was covered with sterile gauze. Healing was seen almost immediately and was quite advanced after 8 weeks. During 4 additional weeks, final closure of the wound occurred. Total healing time for the wound was 17 weeks. The author concludes that wound gels are effective in healing diabetic foot ulcers and that this is a promising therapeutic alternative for patients with refractory foot ulcers.
Related Keywords:
Diabetic foot ulcer, compounding for, Metronidazole, compounded for diabetic foot ulcer, Misoprostol, compounded for diabetic foot ulcer, Nifedipine, compounded for diabetic foot ulcer, Phenytoin, compounded for diabetic foot ulcer, Ulcer, diabetic foot, compounding for, Wound care, of diabetic foot ulcer, compounding for
Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Case Report: Wound Care of a Diabetic Foot Ulcer
Wynn Tom
|
Jul/Aug 2004
Pg. 265-267
|
Compounding Pearls -- Wound Care: Diabetic Foot Ulcers, Part 1
Riepl Mike
|
May/Jun 2020
Pg. 182-186
|
Case Report: Diabetic Foot Ulcer Infection Treated with Topical Compounded Medications
Agbi Kelechi E, Carvalho Maria, Phan Ha, Tuma Cristiane
|
Jan/Feb 2017
Pg. 22-27
|
Compounding Pearls -- Wound Care: Diabetic Foot Ulcers, Part 2
Riepl Mike
|
Jul/Aug 2020
Pg. 278-281
|
Profile of a Practice: Ward Drug Company Diabetic Shoppe and Prescription Compounding Center
Vail Jane
|
Jan/Feb 2003
Pg. 21-23
|
L-Arginine and Ascorbic Acid for Diabetic Foot Ulcers
Gorman Shellie
|
Mar/Apr 2000
Pg. 94-96
|
Case Report: Wound Care of a Diabetic Foot Ulcer
Wynn Tom, Thompson Chad
|
Nov/Dec 2024
Pg. 455-458
|
Current Topical Treatments in Wound Healing - Part 1
Helmke Christopher D
|
Jul/Aug 2004
Pg. 269-274
|
Misoprostol 0.0024% and Phenytoin 5% Diabetic Ulcer Cream
Meece Jerry
|
May/Jun 2003
Pg. 171
|
A Compendium of Compounding Agents and Formulations, Part 2: Metronidazole, Misoprostol, and Phenytoin
Riepl Mike
|
Mar/Apr 2022
Pg. 94-98
|
Diabetic Foot-Care Ointments
Allen Loyd V Jr
|
Mar/Apr 2000
Pg. 130
|
Diabetic Skin-Ulcer Cream
Allen Loyd V Jr
|
Mar/Apr 2000
Pg. 131
|
Compounding in the Pharmacy Curriculum: Beyond the Basics
Hinkle Amanda R, Newton Gail D
|
May/Jun 2004
Pg. 181-185
|
Five Compounds for Treating Diabetes-Related Conditions
Meece Jerry
|
May/Jun 2003
Pg. 170-174
|
The Clinical Pharmacist's Role in Compounding for the Diabetic Patient
Harshbarger Robert, Harshbarger Diana
|
Mar/Apr 2000
Pg. 84-87
|
Case Report: Topical Gel for the Treatment of a Refractory Leg Ulcer
Israel Alan
|
May/Jun 2003
Pg. 176-178
|
Compounding for the Dental Patient: A Focus on Ulcers of the Mouth
Bassani August S, Keim David
|
Nov/Dec 2004
Pg. 436-440
|
Case Report: Lidocaine Mucoadhesive Buccal Tablets for Local Relief of Mouth Ulcers
Young Jennifer L, Bogner Robin H
|
May/Jun 2009
Pg. 214-217
|
A Compendium of Compounding Agents and Formulations, Part 5: Timolol and Beta-glucans
Riepl Mike
|
Sep/Oct 2022
Pg. 364-368
|
Aphthous Ulcer Gel
Allen Loyd V Jr
|
Mar/Apr 2023
Pg. 144
|
Return to Top |